![Short congress report from AACR.NCI.EORTC](http://s1.studyres.com/store/data/007845838_1-ceb212da64be0361327a917b5762436d-300x300.png)
Short congress report from AACR.NCI.EORTC
... confirmed our current view on how to utilize the Wnt-5a pathway in the development antimetastatic therapy. All available data in breast cancer, colorectal cancer and prostate cancer, indicate that the correct approach should be to mimic Wnt-5a in cancer patients with low levels of this protein in th ...
... confirmed our current view on how to utilize the Wnt-5a pathway in the development antimetastatic therapy. All available data in breast cancer, colorectal cancer and prostate cancer, indicate that the correct approach should be to mimic Wnt-5a in cancer patients with low levels of this protein in th ...
EFFICACY OF KETOCONAZOLE IN HORMONE REFRACTORY
... inhibitors should not be taken. These measures may not have been followed by patients resulting in suboptimal bioavailability of the drug. The use of PSA as an endpoint is still a subject of debate at present. However, PSA has been welldocumented as a surrogate marker of response. Changes in PSA may ...
... inhibitors should not be taken. These measures may not have been followed by patients resulting in suboptimal bioavailability of the drug. The use of PSA as an endpoint is still a subject of debate at present. However, PSA has been welldocumented as a surrogate marker of response. Changes in PSA may ...
Prostate Cancer Screening with Prostate
... because of the voluntary PSA screening or some other reasons? Patrick Walsh: The introduction of any new form of treatment for localized prostate cancer requires at least 10 years before a major effect on mortality is seen. The dramatic decline in mortality since 1992 is the result of 2 events— earl ...
... because of the voluntary PSA screening or some other reasons? Patrick Walsh: The introduction of any new form of treatment for localized prostate cancer requires at least 10 years before a major effect on mortality is seen. The dramatic decline in mortality since 1992 is the result of 2 events— earl ...
Some people believe that having cancer means they will die, but
... Some people believe that having cancer means they will die, but that is not always true. Many people live long, healthy healthy lives after they have cancer treatment. And scientists expect the number of cancer survivors to increase over the coming years. Improvements in screening tests (examination ...
... Some people believe that having cancer means they will die, but that is not always true. Many people live long, healthy healthy lives after they have cancer treatment. And scientists expect the number of cancer survivors to increase over the coming years. Improvements in screening tests (examination ...
Increased serum insulin associated with increased risk of prostate
... aggressiveness. Many prostate cancers are quite indolent and may never cause a problem, but it is now impossible to identify such tumors with certainty. Further studies of serum insulin levels in prostate cancer as a biomarker might, therefore, be worthwhile. With more and better biomarkers, many ol ...
... aggressiveness. Many prostate cancers are quite indolent and may never cause a problem, but it is now impossible to identify such tumors with certainty. Further studies of serum insulin levels in prostate cancer as a biomarker might, therefore, be worthwhile. With more and better biomarkers, many ol ...
cardiology - Saint Francis Veterinary Center
... These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. Your veterinarian may suggest certain tests to help confirm or eliminate diagnosis, and to help assess treatment options and likely outcomes. Because individual situations and responses vary, a ...
... These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. Your veterinarian may suggest certain tests to help confirm or eliminate diagnosis, and to help assess treatment options and likely outcomes. Because individual situations and responses vary, a ...
Current status of PSA screening Early detection of prostate cancer
... lung cancer in terms of cancer mortality, and is also an important cause of morbidity. Prostate-specific antigen (PSA), a tumour marker introduced in the late 1980s, is one of the best oncology markers available. It has been used extensively to screen normal healthy men for the disease. About 13% of ...
... lung cancer in terms of cancer mortality, and is also an important cause of morbidity. Prostate-specific antigen (PSA), a tumour marker introduced in the late 1980s, is one of the best oncology markers available. It has been used extensively to screen normal healthy men for the disease. About 13% of ...
Webquest - Indiana University Bloomington
... First clinical study shows 90 percent efficacy in men with pre-malignant lesions Anaheim, Calif. – After a year's oral administration of green tea catechins (GTCs), only one man in a group of 32 at high risk for prostate cancer developed the disease, compared to nine out of 30 in a control, accordin ...
... First clinical study shows 90 percent efficacy in men with pre-malignant lesions Anaheim, Calif. – After a year's oral administration of green tea catechins (GTCs), only one man in a group of 32 at high risk for prostate cancer developed the disease, compared to nine out of 30 in a control, accordin ...
Early detection of highgrade prostate cancer using digital rectal
... DRE results may affect survival in older Caucasian men with low PSA levels, this may support the idea of annual DRE in healthy men even beyond the age of 70 years, when screening for prostate cancer is more controversial [12]. Second, a declining PSA level was associated with a significantly increas ...
... DRE results may affect survival in older Caucasian men with low PSA levels, this may support the idea of annual DRE in healthy men even beyond the age of 70 years, when screening for prostate cancer is more controversial [12]. Second, a declining PSA level was associated with a significantly increas ...
Advanced Prostate Cancer Information Guide
... http://www.mcancer.org/prostate-cancer/high-risk-or-advancedprostate-cancer Description of the High Risk or Advanced Prostate Cancer Program at the UM Comprehensive Cancer Center. ...
... http://www.mcancer.org/prostate-cancer/high-risk-or-advancedprostate-cancer Description of the High Risk or Advanced Prostate Cancer Program at the UM Comprehensive Cancer Center. ...
Anterior and posterior bone scans of a patient with prostate cancer
... prostate biopsy. However, recent data suggest that, among men younger than 50 years, a PSA velocity of 0.6 ng/mL/y may be more appropriate. Percent of free prostate-specific antigen The measurement of bound and free PSA is a recent development that can help to differentiate mildly elevated PSA level ...
... prostate biopsy. However, recent data suggest that, among men younger than 50 years, a PSA velocity of 0.6 ng/mL/y may be more appropriate. Percent of free prostate-specific antigen The measurement of bound and free PSA is a recent development that can help to differentiate mildly elevated PSA level ...
XML - UBC Library - University of British Columbia
... refers to the correct diagnosis of a disease, such as prostate cancer, but the disease has no clinical significance (such as causing symptoms or death) during a patient’s lifetime. It is challenging to compare rates of over-diagnosis between cancer screening programs as this outcome is not commonly ...
... refers to the correct diagnosis of a disease, such as prostate cancer, but the disease has no clinical significance (such as causing symptoms or death) during a patient’s lifetime. It is challenging to compare rates of over-diagnosis between cancer screening programs as this outcome is not commonly ...
T. A. Stamey, et al.The Prostate Specific Antigen Era in the U.S. is
... last 20 years is that men in the United States between 50 and 80 years old have been so intensely screened with serum PSA of 2.5 to 10 ng/ml followed by ever increasing numbers of routine prostatic biopsies (from 6 to 10 –12 to 23 per biopsy session)12–14 that virtually all men with prostate cancer ...
... last 20 years is that men in the United States between 50 and 80 years old have been so intensely screened with serum PSA of 2.5 to 10 ng/ml followed by ever increasing numbers of routine prostatic biopsies (from 6 to 10 –12 to 23 per biopsy session)12–14 that virtually all men with prostate cancer ...
(PDF, Unknown) - European Medical Journal
... for the era that followed and what has taken us through to this point in time.2 Androgen deprivation therapy (ADT), as first-line therapy in the management of advanced prostate cancer (PrC), was initially prescribed in the form of oral oestrogen (diethylstilbestrol [DES]; i.e. medical orchiectomy at ...
... for the era that followed and what has taken us through to this point in time.2 Androgen deprivation therapy (ADT), as first-line therapy in the management of advanced prostate cancer (PrC), was initially prescribed in the form of oral oestrogen (diethylstilbestrol [DES]; i.e. medical orchiectomy at ...
Accurate Diagnosis and Treatment A Remarkable Achievement
... Prostate Cancer Imaging Inaccurate to Accurate Thorough Prostate Cancer Risk Assessment (with PSA) selects men for MRI MRI selects men for biopsy MRI best performed before initial biopsy session (before biopsy artefact) TRUS/MRI fusion targeted biopsy Aggressive cancers diagnosed at the initial biop ...
... Prostate Cancer Imaging Inaccurate to Accurate Thorough Prostate Cancer Risk Assessment (with PSA) selects men for MRI MRI selects men for biopsy MRI best performed before initial biopsy session (before biopsy artefact) TRUS/MRI fusion targeted biopsy Aggressive cancers diagnosed at the initial biop ...
Document
... biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int 2012;110:369-374. ...
... biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int 2012;110:369-374. ...
cme: Early Detection of Prostate Cancer
... et al. (6) have been found useful in this group of patients. Digital rectal palpation alone is not an adequate screening method for prostate cancer and is therefore performed in combination with measurement of the PSA concentration. Before the first PSA level is obtained, the patient must be informe ...
... et al. (6) have been found useful in this group of patients. Digital rectal palpation alone is not an adequate screening method for prostate cancer and is therefore performed in combination with measurement of the PSA concentration. Before the first PSA level is obtained, the patient must be informe ...
PSMA PET/CT imaging and therapy
... PSA levels for <0.2 ng/ml and 0.2 to 2.0 ng/ ml respectively. They reported that positivity rate was positively associated with PSA level and androgen deprivation therapy (ADT). Eiber et al. reported higher positivity rates in 258 patients with biochemical recurrence after radical prostatectomy [23] ...
... PSA levels for <0.2 ng/ml and 0.2 to 2.0 ng/ ml respectively. They reported that positivity rate was positively associated with PSA level and androgen deprivation therapy (ADT). Eiber et al. reported higher positivity rates in 258 patients with biochemical recurrence after radical prostatectomy [23] ...